<?xml version="1.0"?>
<TOCITEMS nbPages="8"><TOCITEMLIST level="0"><ITEM id="0"><STRING>Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hyper ...</STRING><LINK page="1" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST><TOCITEMLIST level="1" idItemParent="0"><ITEM id="1"><STRING>1. Introduction</STRING><LINK page="1" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="2"><STRING>2. Methods</STRING><LINK page="2" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="12"><STRING>3. Results</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="19"><STRING>4. Discussion</STRING><LINK page="6" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="22"><STRING>5. Conclusions</STRING><LINK page="7" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="23"><STRING>Sources of funding</STRING><LINK page="7" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="24"><STRING>Conflict of interest</STRING><LINK page="7" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="25"><STRING>Acknowledgements</STRING><LINK page="7" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="26"><STRING>Appendix A. Supplementary data</STRING><LINK page="7" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="27"><STRING>References</STRING><LINK page="7" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST><TOCITEMLIST level="2" idItemParent="2"><ITEM id="3"><STRING>2.1. Data source</STRING><LINK page="2" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="4"><STRING>2.2. Study population</STRING><LINK page="2" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="5"><STRING>2.3. Diagnostic variables</STRING><LINK page="2" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="6"><STRING>2.4. Outcome criteria</STRING><LINK page="2" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="7"><STRING>2.5. Statistical analysis</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST><TOCITEMLIST level="3" idItemParent="7"><ITEM id="8"><STRING>2.5.1. Derivation of the FAMCAT model</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="9"><STRING>2.5.2. Validation of the FAMCAT model</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="10"><STRING>2.5.3. Sensitivity analysis</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="11"><STRING>2.5.4. Calibration and reclassification</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST><TOCITEMLIST level="2" idItemParent="12"><ITEM id="13"><STRING>3.1. Characteristics of the study population</STRING><LINK page="3" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="14"><STRING>3.2. Multivariate analysis</STRING><LINK page="4" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="15"><STRING>3.3. Discrimination analysis</STRING><LINK page="5" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="18"><STRING>3.4. Calibration and risk reclassification</STRING><LINK page="5" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST><TOCITEMLIST level="3" idItemParent="15"><ITEM id="16"><STRING>3.3.1. Primary analysis</STRING><LINK page="5" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="17"><STRING>3.3.2. Sensitivity analysis</STRING><LINK page="5" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST><TOCITEMLIST level="2" idItemParent="19"><ITEM id="20"><STRING>4.1. Clinical implications</STRING><LINK page="6" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM><ITEM id="21"><STRING>4.2. Strengths and limitations</STRING><LINK page="6" top="794.00" bottom="794.00" left="0.00" right="596.00"/></ITEM></TOCITEMLIST></TOCITEMS>
